| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 06/23/1994 | WO1994013661A1 Substituted pyrazoles as crf antagonists |
| 06/23/1994 | WO1994013300A1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
| 06/21/1994 | US5322681 Chelating compounds |
| 06/15/1994 | EP0601547A1 Crystalline salts of optically active aminocoumaran derivatives, their production and use |
| 06/15/1994 | EP0600970A1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 06/15/1994 | EP0357693B1 Molecular sieve arrangement |
| 06/14/1994 | US5321023 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 06/10/1994 | CA2111033A1 Crystalline salts of optically active aminocoumaran derivatives, their production and use |
| 06/08/1994 | CN1087531A Oily preparation and method of production thereof |
| 06/07/1994 | CA1330082C 2-(8-quinolinoxy)-alkan-2-one dialkyl ketals or acetals, a process for their preparation, and their use as antidotes |
| 06/01/1994 | EP0598753A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 05/31/1994 | US5316756 NMR imaging using paramagnetic chelates having hydroxyalkyl-substituted amide groups |
| 05/24/1994 | US5314878 Composition for removing or inactivating harmful components in blood or other extracellular body fluids |
| 05/11/1994 | EP0596032A1 Induction of cytotoxic t-lymphocyte responses |
| 05/04/1994 | EP0595311A1 Pharmaceutical composition consisting of flupirtin and morphine for the treatment of pain and to avoid a morphine addiction |
| 05/04/1994 | EP0594667A1 Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides |
| 04/20/1994 | CN1085557A Enatiomeric hydroxylated xanthine compounds |
| 04/13/1994 | EP0591584A1 N-Alkyl-3-phenyl-3-(2-halo-substituted phenoxy)Propylamines as norepinephrine uptake inhibitors |
| 04/13/1994 | EP0396616B1 Reduction of side effects of cancer therapy |
| 03/31/1994 | WO1994006459A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/31/1994 | CA2145179A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/17/1994 | WO1994005655A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 03/17/1994 | CA2141863A1 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | CN1083703A Pharmaceutical composition with functions of antialcohol, promoting change of energy, of mucosa of stomach, acidification, secretion, antradiation and anticholera |
| 03/08/1994 | US5292745 Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 03/03/1994 | WO1994004532A1 3-oxo-pyrido(1,2-a^_)benzimidazole-4-carboxyl and 4-oxo-azepino(1,2-a^_)benzimidazole-5-carboxyl derivatives useful in treating central nervous system disorders |
| 03/03/1994 | WO1994004498A1 3-hydroxypyridin-4-one derivatives as chelating agents |
| 03/03/1994 | WO1994004177A1 Methods useful in endotoxin prophylaxis and therapy |
| 03/03/1994 | CA2142295A1 Methods useful in endotoxin prophylaxis and therapy |
| 03/02/1994 | EP0584347A1 Enantiomeric hydroxylated xanthine compounds |
| 03/02/1994 | EP0584285A1 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 02/17/1994 | WO1994003555A1 Antioxidant |
| 02/17/1994 | WO1994003455A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 02/17/1994 | WO1994003437A1 Benzodiazepine derivatives |
| 02/17/1994 | WO1994003179A1 Crystalline amifostine compositions and methods for the preparation and use of same |
| 02/17/1994 | CA2141332A1 Pyridoindolobenzodiazepines and derivatives as antipsychotics |
| 02/17/1994 | CA2140009A1 Benzodiazepine derivatives |
| 02/15/1994 | US5286718 Administering monophosphoryl lipid A or its 3-deacylated derivative |
| 01/25/1994 | US5281624 Neurological disorders associated with norepinephrine imbalance |
| 01/20/1994 | WO1994001099A1 Pharmaceutical composition having anti-alcohol, radioprotecting and anti-choleraic activity and stimulating energy metabolism, stomach mucous membrane acid-generation and secretion functions |
| 01/11/1994 | US5278332 Ethers of myoinsitol phosphate for drugs or foods |
| 01/11/1994 | US5277907 Regulation of the immune system |
| 01/11/1994 | CA1326029C 4-thiazolidine-carboxylic acid derivative, its preparation and pharmaceutical compositions containing it |
| 01/05/1994 | EP0576619A1 1,2-dithiole-3-thione derivative-based therapeutical compositions. |
| 01/05/1994 | EP0576420A1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it. |
| 01/05/1994 | CN1080172A Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
| 12/29/1993 | EP0575479A1 Production and use of butyrylcholinesterase |
| 12/21/1993 | US5272080 Production of butyrylcholinesterase |
| 12/08/1993 | EP0572922A1 Synergistic combinations comprising lipoic acid and vitamines in medicaments |
| 11/25/1993 | WO1993023411A1 Compounds based on palladium and on derivatives of aromatic amines and method of obtaining them |
| 11/25/1993 | WO1993017684A3 Enantiomeric hydroxylated xanthine compounds |
| 11/23/1993 | US5264225 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same |
| 11/16/1993 | US5262439 Soluble analogs of probucol |
| 11/16/1993 | US5262169 Tablets and granulates containing mesna as active substance |
| 11/11/1993 | WO1993021914A1 Soluble analogs of probucol |
| 11/09/1993 | CA1324143C Quinoline dioic acids and amides |
| 11/03/1993 | EP0567498A1 Pharmaceutical composition containing granisetron and dexamethasone |
| 11/03/1993 | EP0374182B1 Biospecific polymers |
| 11/02/1993 | US5258175 Administering acidic dextrin derivative |
| 10/28/1993 | WO1993020696A1 Regulation of the immune system |
| 10/28/1993 | WO1993016713A3 Use of muramyl peptide for the treatment of toxicity |
| 10/28/1993 | WO1993009222A3 Transfection of vertebrate cells e.g. by homologous recombination |
| 10/14/1993 | WO1993020076A1 Catalytic antibodies against cocaine and methods of using and producing same |
| 10/14/1993 | WO1993020061A1 4-[4'-piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof |
| 10/14/1993 | WO1993020058A1 Novel cardioprotective agents |
| 10/14/1993 | CA2133461A1 4-[4'piperidinyl or 3'-pirrolidinyl] substituted imidazoles as h3-receptor antagonists and therapeutic uses thereof |
| 10/06/1993 | EP0563145A1 Chelating agents |
| 10/06/1993 | CN1076929A Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
| 10/05/1993 | CA1322720C Anticarcinogenic agents |
| 09/28/1993 | US5248697 For treatment of radiation associated oxidative damage in tissue |
| 09/16/1993 | WO1993017684A2 Enantiomeric hydroxylated xanthine compounds |
| 09/15/1993 | EP0560275A1 Use of L-carnitine for treating carnitine-depleted HIV-seropositive patients |
| 09/15/1993 | EP0559845A1 Use of compounds in preventing endotoxin shock |
| 09/02/1993 | WO1993016713A2 Use of muramyl peptide for the treatment of toxicity |
| 08/19/1993 | WO1993015745A1 Methods and compositions of a polymer (poloxamer) for cell repair |
| 08/18/1993 | EP0368972B1 Method of safely providing anesthesia or conscious sedation |
| 08/11/1993 | EP0417238B1 Silicon-containing environment-protective agent adsorbing radioactive metal isotopes and toxic heavy metals and a pharmaceutical composition containing same |
| 08/10/1993 | US5235055 Antipsychotic quinoline derivatives of benzodioxanmethylamine |
| 08/05/1993 | CA2626680A1 Peritoneal dialysis composition and method usable during and after peritonitis |
| 08/04/1993 | EP0553890A1 Diphenyl heteroalkyl derivatives, their preparation, as well as medicinal and cosmetic preparations prepared therefrom |
| 08/04/1993 | EP0553884A1 Purified tetrahydropyrimidine derivatives and pharmaceutical compositions comprising them |
| 07/31/1993 | CA2088390A1 Tetrahydropyrimidine derivatives and pharmaceutical compositions containing them |
| 07/28/1993 | EP0552237A1 Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of gaba brain receptor ligands |
| 07/22/1993 | WO1993014115A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/22/1993 | WO1993013805A1 Cytotoxic drug therapy |
| 07/22/1993 | WO1993002693A3 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 07/22/1993 | CA2123576A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/08/1993 | WO1993012778A1 Method and composition for ameliorating tissue damage due to ischemia and reperfusion |
| 07/07/1993 | EP0549660A1 Enhancement of glutathione levels with glutamine |
| 06/29/1993 | CA1319615C Method of preparing a solid composition of lactulose, and composition so obtained |
| 06/16/1993 | EP0546118A1 Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 06/16/1993 | EP0546063A1 Toxic agent protective compounds, compositions and uses |
| 06/09/1993 | EP0544832A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 06/08/1993 | US5217964 Free radical scavenger; prevent cell damage |
| 06/01/1993 | US5216159 Certain cycloalkyl and azacycloalkyl pyrrolopyrimidines; a new class of GABA brain receptor ligands |
| 05/19/1993 | EP0542398A1 Rice extract useful as active oxygen scavenger |
| 05/13/1993 | WO1993009222A2 Transfection of vertebrate cells e.g. by homologous recombination |
| 05/13/1993 | CA2122991A1 Transfection of vertebrate cells by homologous recombination |
| 05/12/1993 | EP0541214A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |